title: A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy.
abstract: OBJECTIVE
  To determine the impact of thiazolidinediones (TZD) on changes in limb fat mass in HIV-infected individuals, particularly in those not receiving a thymidine analogue.
  
  
  METHODS
  Individual patient data from placebo-controlled, randomized trials of rosiglitazone (n = 5) or pioglitazone (n = 1) were combined. Generalized estimating equation (GEE) models were used to estimate the treatment effect on changes in limb fat mass.
  
  
  RESULTS
  In the combined dataset of 427 patients, the baseline median age was 45 years, 86% were male, 80% were Caucasian, 63% were receiving stavudine (d4T) or zidovudine (AZT), 66% were on protease inhibitors, and median body mass index was 23 kg/m(2). In a univariate GEE model, TZD was associated with an increase in limb fat mass (coeff = 0.14 kg vs placebo, P = .04). In a multivariable GEE model, patients receiving pioglitazone had significantly higher limb fat mass gains (coeff = 0.35 kg, P < or = .01) compared to patients receiving placebo, while patients on rosiglitazone did not (coeff = 0.05 kg, P = .48). Interactions between thymidine analogue use and rosiglitazone and pioglitazone were not significant.
  
  
  CONCLUSIONS
  In this meta-analysis, pioglitazone therapy was more effective than placebo to increase limb fat mass whereas rosiglitazone was not significantly better than placebo. The effectiveness of these drugs did not vary according to whether the patients were receiving thymidine analogues.
authors.affiliation: University of Toronto, Toronto, Canada. raboud@lunenfeld.ca
authors.forename: Janet M
authors.initials: JM
authors.lastname: Raboud
authors.forename: Christina
authors.initials: C
authors.lastname: Diong
authors.forename: Andrew
authors.initials: A
authors.lastname: Carr
authors.forename: Steven
authors.initials: S
authors.lastname: Grinspoon
authors.forename: Kathleen
authors.initials: K
authors.lastname: Mulligan
authors.forename: Jussi
authors.initials: J
authors.lastname: Sutinen
authors.forename: William
authors.initials: W
authors.lastname: Rozenbaum
authors.forename: Rodrigo B
authors.initials: RB
authors.lastname: Cavalcanti
authors.forename: Handan
authors.initials: H
authors.lastname: Wand
authors.forename: Dominique
authors.initials: D
authors.lastname: Costagliola
authors.forename: Sharon
authors.initials: S
authors.lastname: Walmsley
mesh_terms: D000328:Adult; D050218:Body Fat Distribution; D005260:Female; D006678:HIV; D015658:HIV Infections / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D008060:Lipodystrophy / Q000188:drug therapy* / Q000821:virology*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D000077205:Pioglitazone; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077205:Pioglitazone
references.citation: J Infect Dis. 2005 May 15;191(10):1686-96
references.pmid: 15838796
references.citation: AIDS. 2004 Apr 30;18(7):1029-36
references.pmid: 15096806
references.citation: J Infect Dis. 2008 Dec 15;198(12):1794-803
references.pmid: 18954260
references.citation: Antivir Ther. 2008;13(1):67-76
references.pmid: 18389900
references.citation: J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):367-71
references.pmid: 15776544
references.citation: J Infect Dis. 2007 Jun 15;195(12):1754-61
references.pmid: 17492590
references.citation: JAMA. 2007 Sep 12;298(10):1189-95
references.pmid: 17848653
references.citation: N Engl J Med. 2007 Jun 14;356(24):2457-71
references.pmid: 17517853
references.citation: AIDS. 2003 May 2;17(7):971-9
references.pmid: 12700446
references.citation: Ann Intern Med. 2000 Aug 15;133(4):263-74
references.pmid: 10929166
references.citation: AIDS. 2006 Oct 24;20(16):2043-50
references.pmid: 17053350
references.citation: AIDS. 2002 Feb 15;16(3):353-8
references.pmid: 11834946
references.citation: AIDS. 2002 Jan 4;16(1):13-20
references.pmid: 11741158
references.citation: Metabolism. 1999 Sep;48(9):1102-7
references.pmid: 10484048
references.citation: Biometrics. 1986 Mar;42(1):121-30
references.pmid: 3719049
references.citation: JAMA. 2002 Jul 10;288(2):207-15
references.pmid: 12095385
references.citation: Clin Infect Dis. 2004 Jan 15;38(2):263-70
references.pmid: 14699460
references.citation: AIDS. 2009 Jun 1;23(9):1109-18
references.pmid: 19417580
references.citation: AIDS. 1999 Sep 10;13(13):1659-67
references.pmid: 10509567
references.citation: Ann Intern Med. 2004 May 18;140(10):786-94
references.pmid: 15148065
references.citation: Antimicrob Agents Chemother. 2002 Mar;46(3):716-23
references.pmid: 11850253
references.citation: Diabetes Care. 1999 Jun;22(6):908-12
references.pmid: 10372240
references.citation: AIDS. 2005 Nov 4;19(16):1807-18
references.pmid: 16227788
references.citation: Arch Intern Med. 2004 Oct 25;164(19):2097-104
references.pmid: 15505122
references.citation: Lancet. 2001 Mar 3;357(9257):651-2
references.pmid: 11247544
references.citation: Am J Ther. 2008 Nov-Dec;15(6):506-11
references.pmid: 19127132
references.citation: Lancet. 2001 Mar 3;357(9257):686-7
references.pmid: 11247555
references.citation: AIDS. 2007 Jan 2;21(1):47-57
references.pmid: 17148967
references.citation: J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):535-40
references.pmid: 17057609
references.citation: Lancet. 1999 Sep 25;354(9184):1112-5
references.pmid: 10509516
references.citation: N Engl J Med. 2005 Jan 6;352(1):48-62
references.pmid: 15635112
references.citation: J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):139-47
references.pmid: 17106274
references.citation: Lancet. 2004 Feb 7;363(9407):429-38
references.pmid: 14962523
references.citation: AIDS. 2010 Jun 1;24(9):1291-8
references.pmid: 20453626
references.citation: J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):163-70
references.pmid: 12394794
references.citation: Antivir Ther. 2003 Jun;8(3):199-207
references.pmid: 12924536
references.citation: J Acquir Immune Defic Syndr. 2003 May 1;33(1):29-33
references.pmid: 12792352